Rafael Madero Marroquín/X
Dec 31, 2024, 11:27
Rafael Madero Marroquín: CD58 loss as a mechanism of resistance to blina and CAR-T therapy
Rafael Madero Marroquín, Hematology Oncology Fellow at The University of Chicago Medical Center, shared on X:
“CD58 loss has been described as a mechanism of resistance to blina and CAR-T therapy.
Our work suggests CD58 expression, using mean fluorescence intensity, does NOT impact the rate of flow MRD negativity after inotuzumab in B-ALL.
Thank you Anand Patel for your mentorship!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 26, 2025, 00:17
Apr 25, 2025, 23:37
Apr 25, 2025, 19:33
Apr 25, 2025, 19:16
Apr 25, 2025, 19:06
Apr 25, 2025, 18:59